Actinogen Medical Limited
ATGGF
$0.025
$0.0014.17%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.08% | 13.10% | 34.84% | 11.65% | -17.99% |
| Total Depreciation and Amortization | -0.07% | -1.42% | -2.86% | -0.66% | 0.15% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 59.69% | 178.57% | 269.80% | 142.79% | -17.55% |
| Change in Net Operating Assets | 187.19% | 85.83% | -4,253.71% | -4,253.71% | -4,253.71% |
| Cash from Operations | 57.37% | 46.25% | 31.07% | -18.88% | -89.72% |
| Capital Expenditure | -348.15% | -37.61% | 63.86% | 72.33% | 78.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -348.15% | -37.61% | 63.86% | 72.33% | 78.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 33.99% | 19.89% | 4.14% | -6.23% | -17.09% |
| Issuance of Common Stock | -35.95% | 15.37% | 113.39% | 270.93% | 2,015.79% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 50.22% | -10.01% | -151.26% | -385.76% | -- |
| Cash from Financing | -18.43% | 27.40% | 114.75% | 273.02% | 2,028.10% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 658.59% | 975.25% | 458.34% | 211.89% | 111.94% |